Company / Capital Expenditures
PLUS THERAPEUTICS, INC. Capital Expenditures History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$146.0K
FY2025
5-year range
$67.0K / $611.0K
FY2021-FY2025
Trend
-8.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 9 years, ranging from $67,000 in FY2017 to $1M in FY2014.
Based on SEC 10-K filings.
$146,000 in FY2025 with a 10-year CAGR of -11.9%.
Improved from $67,000 to $146,000 over the past 8 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -11.9%
Key checks
Key Insights
- In FY2025, capital expenditures decreased 8.8% year-over-year.
- Peak capital expenditures was recorded in FY2014.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $146.0K | -8.8% |
| FY2024 | $160.0K | - |
| FY2018 | - | - |
| FY2017 | $67.0K | -89.0% |
| FY2016 | $611.0K | +17.7% |
| FY2015 | $519.0K | -56.9% |
| FY2014 | $1.2M | +115.0% |
| FY2013 | $560.0K | -8.2% |
| FY2012 | $610.0K | +176.0% |
| FY2011 | $221.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026